Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was evaluate the efficacy and safety of alogliptin, once dairy (QD)
combined with metformin taken twice daily (BID) or three times daily (TID) in type 2 diabetic
patients with uncontrolled blood glucose.